Apeiron Biologics AG
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Apeiron Biologics AG
Bristol makes its own deal with Celgene ally Dragonfly, while Gilead ends virology partnerships with Durect and Precision BioSciences.
Dozens of life science companies are working to find effective treatments for COVID-19. In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into some of the efforts that are under way on this front.
Peter Llewellyn-Davies, CEO and chief financial officer of Apeiron Biologics, talks to Lucie Ellis, executive editor of In Vivo, on the sidelines of the recent BIO-Europe Spring conference about the company’s pipeline and partnering strategy.